Literature DB >> 19940860

CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.

Sandra Klein1, Cosima C Kretz, Peter H Krammer, Annegret Kuhn.   

Abstract

It has recently been suggested that a lack of CD127 expression can be used to identify human CD4(+) regulatory T cells (Tregs), especially when combined with CD25. Therefore, we analyzed CD4(+)CD25(+)CD127(low/-) cells and compared their frequency and expression pattern with those of FoxP3(+) Tregs using multiparameter flow cytometry analysis. We obtained human peripheral blood cells from 20 normal healthy donors and determined the number of CD25(+)CD127(low/-) cells as a percentage of CD4(+) T cells in the same panel used for CD4(+)CD25(+)FoxP3(+) cells. In contrast to CD4(+)CD25(+)FoxP3(+) cells, gating of a clear CD4(+)CD25(+)CD127(low/-) population was difficult. Moreover, we demonstrated that there was a high percentage (34.0+/-15.1%) of CD127(low/-) cells that did not express FoxP3 and, conversely, that there was a high percentage (30.3+/-7.4%) of CD127(+) cells that expressed FoxP3, suggesting that these markers did not represent the same population of Tregs. These data were also confirmed in blood samples from patients with systemic scleroderma. Thus, isolation of pure Treg populations for in vitro functional studies is a challenge, explaining the varying results by different groups in clinical studies. The data from this study have important implications for carrying out a quantitative analysis of Tregs in human samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940860     DOI: 10.1038/jid.2009.313

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  28 in total

1.  CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood.

Authors:  Ning Yu; Xiaomei Li; Weiya Song; Dongmei Li; Daliang Yu; Xiaofeng Zeng; Mengtao Li; Xiaomei Leng; Xiangpei Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

2.  Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia.

Authors:  Ying Yang; Yong-jun Liu; Shao-tao Tang; Li Yang; Jun Yang; Guo-qing Cao; Jing-hui Zhang; Xin-xin Wang; Yong-zhong Mao
Journal:  Pediatr Surg Int       Date:  2013-12       Impact factor: 1.827

3.  Regulatory T-cell detection by flow cytometry and systemic sclerosis.

Authors:  Sujoy Khan
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

Review 4.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

5.  Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.

Authors:  Lucas C M Arruda; Kelen C R Malmegrim; João R Lima-Júnior; Emmanuel Clave; Juliana B E Dias; Daniela A Moraes; Corinne Douay; Isabelle Fournier; Hélène Moins-Teisserenc; Antônio José Alberdi; Dimas T Covas; Belinda P Simões; Pauline Lansiaux; Antoine Toubert; Maria Carolina Oliveira
Journal:  Blood Adv       Date:  2018-01-23

Review 6.  Foxp3, Regulatory T Cell, and Autoimmune Diseases.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Qin Liu; Fan Pan; Xiang-Pei Li
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

7.  Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease.

Authors:  Wenwen Yan; Lemin Wang; Jinfa Jiang; Wenjun Xu; Zhu Gong; Qianglin Duan; Chuanrong Li; Haoming Song; Lin Che; Yuqin Shen; Lin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.

Authors:  Wen-Hua Xu; Ai-Mei Zhang; Ming-Shan Ren; Xu-Dong Zhang; Fang Wang; Xiu-Cai Xu; Qing Li; Jian Wang; Bang-Sheng Din; Yuan-Bo Wu; Gui-Hai Chen
Journal:  J Clin Immunol       Date:  2012-03-31       Impact factor: 8.317

9.  The type of responder T-cell has a significant impact in a human in vitro suppression assay.

Authors:  Srikanta Jana; Hope Campbell; Jeffrey Woodliff; Jill Waukau; Parthav Jailwala; Jugal Ghorai; Soumitra Ghosh; Sanja Glisic
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

10.  Expression and significance of CD4(+)CD25(+)CD127(-) regulatory T cells in peripheral blood of patients with different phenotypes of Guillain-Barré syndrome.

Authors:  Hao Wang; Li Li; Yin Zhang; Shu-Chao Pan; An-Qiang Chen; Wei-Dong Qian
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.